title: [Myelitis following vaccination against tick-borne encephalitis].
abstract: Tick-borne encephalitis is a significant concern in endemic regions, and in rare cases it may even be fatal. There is no specific treatment for the disease. Vaccines from two manufacturers are available against tick-borne encephalitis, both considered effective and safe. Severe adverse effects due to tick-borne encephalitis vaccine are rare. We describe the first severe myelitis detected in Finland following vaccination against tick-borne encephalitis.
authors.affiliation: Pohjois-Pohjanmaan Sairaanhoitopiiri, Kuvantamisen Vastuualue.
authors.forename: Pieta
authors.initials: P
authors.lastname: Ipatti
authors.forename: Tapani
authors.initials: T
authors.lastname: Tikkakoski
authors.forename: Seppo
authors.initials: S
authors.lastname: Tuisku
mesh_terms: D000818:Animals; D004675:Encephalitis, Tick-Borne / Q000517:prevention & control*; D005387:Finland; D006801:Humans; D009187:Myelitis / Q000139:chemically induced*; D014611:Vaccination / Q000009:adverse effects*